Enzo Biochem, Inc. (ENZ) Reports Q2 Loss of $0.04
Get Alerts ENZ Hot Sheet
Join SI Premium – FREE
Enzo Biochem, Inc. (NYSE: ENZ) reported Q2 EPS of ($0.04), versus ($0.11) reported last year. Revenue for the quarter came in at $25 million, versus $23.7 million reported last year.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Diana Shipping withdraws bid to acquire Genco Shipping
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share